X

Science

China Says US Tariff Hikes No Longer Make Economic Sense

China has stated that the recent tariff hikes imposed by the United States no longer make sense from an economic… Read More

Study Finds Common Genetic Variants Linked to Drug-Resistant Epilepsy

A new study has found that some common genetic changes may be linked to drug-resistant epilepsy. This condition affects many… Read More

Cold Feet and Heavy Legs Could Be a Sign of Varicose Veins, Says Study

If you often feel cold feet or heaviness in your legs, it might be more than just tiredness or cold… Read More

India Ranks 2nd Globally in Direct-to-Consumer Sector Funding in 2024: Report

India has secured the second spot in the world for receiving the highest amount of funding in the direct-to-consumer (D2C)… Read More

Mattresses for Babies and Kids Containing Harmful Chemicals May Increase Health Risks

Recent studies show that mattresses made for babies and kids could contain harmful chemicals that may increase health risks. These… Read More

Combining Two Low-Cost Drugs May Help Reduce Risk of Heart Attack and Stroke

A new study suggests that combining two affordable medications may help reduce the risk of heart attacks and strokes. This… Read More

India’s Rooftop Solar Energy Capacity Set to Reach 25-30 GW by FY27

India plans to increase its rooftop solar energy capacity to 25-30 gigawatts (GW) by the end of the financial year… Read More

86% of Indian Companies Now Have a GenAI Strategy, Surpassing Global Trends: Report

A new report says that 86% of Indian companies have already made a plan to use Generative Artificial Intelligence (GenAI)… Read More

Celltrion Receives Interchangeability Approval for Humira Biosimilar in the US

Celltrion, a global biopharmaceutical company, has received approval from the U.S. Food and Drug Administration (FDA) to market its biosimilar… Read More

Indian FMCG Companies Set to Finish FY25 with Single-Digit Revenue Growth, Expect Favorable Base in FY26

Indian FMCG (Fast-Moving Consumer Goods) companies are likely to end the financial year 2025 (FY25) with single-digit revenue growth. The… Read More